Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial

Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial

The Lancet ◽

10.1016/s0140-6736(15)60553-0 ◽

2015 ◽

Vol 385 (9984) ◽

pp. 2272-2279 ◽

Cited By ~ 93

Author(s):

Feng-Cai Zhu ◽

Li-Hua Hou ◽

Jing-Xin Li ◽

Shi-Po Wu ◽

Pei Liu ◽

...

Keyword(s):

Preliminary Report ◽

Recombinant Adenovirus ◽

Phase 1 ◽

Adenovirus Type ◽

Healthy Adults ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 1 Trial ◽

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet ◽

10.1016/s0140-6736(20)31605-6 ◽

2020 ◽

Vol 396 (10249) ◽

pp. 479-488 ◽

Cited By ~ 137

Author(s):

Feng-Cai Zhu ◽

Xu-Hua Guan ◽

Yu-Hua Li ◽

Jian-Ying Huang ◽

Tao Jiang ◽

...

Keyword(s):

Recombinant Adenovirus ◽

Adenovirus Type ◽

Healthy Adults ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Trial ◽

Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet ◽

10.1016/s0140-6736(16)32617-4 ◽

2017 ◽

Vol 389 (10069) ◽

pp. 621-628 ◽

Cited By ~ 84

Author(s):

Feng-Cai Zhu ◽

Alie H Wurie ◽

Li-Hua Hou ◽

Qi Liang ◽

Yu-Hua Li ◽

...

Keyword(s):

Sierra Leone ◽

Recombinant Adenovirus ◽

Adenovirus Type ◽

Healthy Adults ◽

Phase 2 ◽

Single Centre ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Trial ◽

Decision letter for "A Randomized Double-Blind Placebo-Controlled First-In-Human Phase 1 Trial of TransCon PTH in Healthy Adults"

10.1002/jbmr.4016/v3/decision1 ◽

2020 ◽

Keyword(s):

Phase 1 ◽

Healthy Adults ◽

Double Blind ◽

Double Blind Placebo ◽

Review for "A Randomized Double-Blind Placebo-Controlled First-In-Human Phase 1 Trial of TransCon PTH in Healthy Adults"

10.1002/jbmr.4016/v1/review2 ◽

2019 ◽

Keyword(s):

Phase 1 ◽

Healthy Adults ◽

Double Blind ◽

Double Blind Placebo ◽

Safety, tolerability, and preliminary immunogenicity of a recombinant Staphylococcus aureus vaccine (RSAV) in healthy adults between 18 and 65 years in China: study protocol for a randomized, double-blind, placebo-controlled, phase 1 trial

Journal of Public Health and Emergency ◽

10.21037/jphe.2016.12.11 ◽

2017 ◽

Vol 1 ◽

pp. 25-25

Author(s):

Yuan-Yuan Zhu ◽

Jing-Xin Li ◽

Hao Zeng ◽

Ming Zeng ◽

Fan-Yue Meng ◽

...

Keyword(s):

Staphylococcus Aureus ◽

Study Protocol ◽

Phase 1 ◽

Healthy Adults ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 1 Trial ◽

China Study

H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial

The Lancet Infectious Diseases ◽

10.1016/s1473-3099(15)00378-3 ◽

2016 ◽

Vol 16 (3) ◽

pp. 303-310 ◽

Cited By ~ 21

Author(s):

Larisa Rudenko ◽

Irina Isakova-Sivak ◽

Anatoly Naykhin ◽

Irina Kiseleva ◽

Marina Stukova ◽

...

Keyword(s):

Influenza Vaccine ◽

Phase 1 ◽

Healthy Adults ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 1 Trial ◽

Live Attenuated Influenza Vaccine

Review for "A Randomized Double-Blind Placebo-Controlled First-In-Human Phase 1 Trial of TransCon PTH in Healthy Adults"

10.1002/jbmr.4016/v2/review3 ◽

2020 ◽

Keyword(s):

Phase 1 ◽

Healthy Adults ◽

Double Blind ◽

Double Blind Placebo ◽

Review for "A Randomized Double-Blind Placebo-Controlled First-In-Human Phase 1 Trial of TransCon PTH in Healthy Adults"

10.1002/jbmr.4016/v2/review2 ◽

2020 ◽

Keyword(s):

Phase 1 ◽

Healthy Adults ◽

Double Blind ◽

Double Blind Placebo ◽

Review for "A Randomized Double-Blind Placebo-Controlled First-In-Human Phase 1 Trial of TransCon PTH in Healthy Adults"

10.1002/jbmr.4016/v2/review1 ◽

2020 ◽

Keyword(s):

Phase 1 ◽

Healthy Adults ◽

Double Blind ◽

Double Blind Placebo ◽